Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialNazlı Dizman, Sumanta K. Pal|Nature Medicine|2022Cited by 453
Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced CancersChristopher J.D. Wallis, Zachary Klaassen, Mohit Butaney et al.|JAMA Oncology|2019Cited by 302
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaVadim S. Koshkin, Brian I. Rini, Pedro C. Barata et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 184
Papillary carcinoma of the breast: an overviewSumanta K. Pal, George Somlo, Sean K. Lau et al.|Breast Cancer Research and Treatment|2010Cited by 142
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Vivek Subbiah, Justin F. Gainor et al.|Nature Reviews Clinical Oncology|2021Cited by 140